p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons

p53, initially considered a tumor suppressor, has been the subject of research related to cancer treatment resistance in the last 30 years. The unfavorable response to multimodal therapy and the higher recurrence rate, despite an aggressive approach, make HNSCC a research topic of interest for impro...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: MDPI AG 2022-12-01
Seri Bilgileri:Diagnostics
Konular:
Online Erişim:https://www.mdpi.com/2075-4418/12/12/3052